Kevin Feeley
CIK 1944119 · CHIEF FINANCIAL OFFICER · last filed 2026-09-18
Kevin Feeley is a CHIEF FINANCIAL OFFICER who has filed 98 SEC Form 4 insider transactions across 3 companies since 2022. The most recent filing, for WGS, was dated Sep 18, 2026. Across all open-market trades the lifetime net is −$15.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.9M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
WGSWW price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
333 LUDLOW STREET, NORTH TOWER, 8TH FL.
STAMFORD, CT 06902
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| WGS | CHIEF FINANCIAL OFFICER | 48,087 | $61.26 | $2.95M | -$503.3K | 3 | 2026-09-18 |
| GeneDx Holdings Corp. (WGSWW) Delisted | CHIEF FINANCIAL OFFICER | 43,683 | $0.00 | $9 | -$15.29M | 67 | 2026-06-18 |
| GeneDx Holdings Corp. (SMFRW) Delisted | Chief Financial Officer | 15,209 | $0.02 | $365 | -$3.4K | 3 | 2022-12-14 |
Recent Filings
98 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-09-18 | WGS | Mixed | +3,469 | -$363.9K | EDGAR |
| 2026-09-11 | WGS | Mixed | +1,177 | -$108.2K | EDGAR |
| 2026-09-03 | WGS | Mixed | +345 | -$31.2K | EDGAR |
| 2026-09-01 | WGS | Notice (144) | −5,410 | -$458.5K | EDGAR |
| 2026-06-18 | GeneDx Holdings Corp. (WGSWW) Delisted | Mixed | +3,468 | -$226.6K | EDGAR |
| 2026-06-11 | GeneDx Holdings Corp. (WGSWW) Delisted | Mixed | +1,196 | -$68.1K | EDGAR |
| 2026-06-03 | GeneDx Holdings Corp. (WGSWW) Delisted | Mixed | +348 | -$19.1K | EDGAR |
| 2026-05-01 | GeneDx Holdings Corp. (WGSWW) Delisted | Mixed | +362 | -$25.6K | EDGAR |
| 2026-04-29 | WGS | Notice (144) | −5,804 | -$366.0K | EDGAR |
| 2026-03-30 | GeneDx Holdings Corp. (WGSWW) Delisted | Mixed | +7,432 | -$557.1K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.